Pepsi’s Jimmy V Vending Machines Raise Nearly $50,000 for The V Foundation
The V Foundation for Cancer Research, one of the nation’s leading cancer research funding organizations, is pleased to announce that Pepsi Bottling Ventures has raised $49,240 for cancer research. Over a two-year period, Pepsi Bottling Ventures’ customers donated their commission of the Jimmy V vending machines to the initiative, which is expected to continue and expand in 2015.
The V Foundation awards 100 percent of all direct cash donations to cutting-edge cancer research.
“This program gives us funding and visibility,” said Susan Braun, CEO of The V Foundation. “The recognition of the V logo alongside Pepsi’s strong brand is powerful. The funds help us save lives through cancer research. It’s a great combination.”
With 467 dedicated vending machines across North Carolina and in the Conway and Myrtle Beach, South Carolina markets, Pepsi Bottling Ventures’ customers deferred $0.08 of each $1.00 beverage purchased from January 2013 to December 2014 to the program. In the first calendar year, 158 machines raised nearly $9,000. With such early success, 309 machines were added to the program in 2014, raising an additional $40,252. Pepsi Bottling Ventures, the nation’s largest privately held manufacturer, seller and distributor of Pepsi-Cola beverages, will continue to make the Jimmy V vending machine program available in 2015.
“I could not be more pleased with the progress of the Jimmy V vending program and the generosity of our customers who give back to our community through this program,” said Randy Quirk, Vice President of Foodservice Sales at North Carolina-based Pepsi Bottling Ventures. “We look forward to many more years of giving.”
Featured May 11th
The V Foundation and Parker Institute for Cancer Immunotherapy Announce Partnership to Co-Fund GrantsRead More
Featured May 10th
16th Annual Dick Vitale Gala Raises Over $5M for Pediatric Cancer ResearchRead More
Featured April 28th
Pepsi Bottling Ventures’ Jimmy V Vending Machines Raise Nearly $800,000 for Cancer ResearchRead More